The global cervical cancer treatment market is experiencing significant growth, fueled by the increasing prevalence of cervical cancer worldwide. In 2024, the market was valued at USD 7.24 billion and is projected to expand at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2034, reaching an estimated value of USD 12.65 billion by 2034. This article delves into the key drivers of this...